Puma Biotechnology, Inc. (NYSE:PBYI) Analyst Opinion

Puma Biotechnology, Inc. (NYSE:PBYI) stock is presently standing at about $36.50 and lots of equity research firms seem to have a target price set on …

Leave a Comment